Loading…
Employees: 1,382
Size Viemed Healthcare (VMD) is a United States Health Care company (Hospital/Nursing Management) with a market value of $348M, the 2985th largest of 3,117 United States companies the cockpit tracks. Shares closed at $9.13 on 6 Nov 2026.
Performance Over six months the shares gained 2.1%, against -7.2% for the median peer and -1.1% for the United States market (cap-weighted) — 8th highest of 20 in its peer set.
Growth Revenue grew 25.2% over the last twelve months (peer median +10.9%); the operating margin is 8.5% (peer median 9.5%).
Valuation It trades at 18.1× forward earnings against a peer median of 22.5× (5th cheapest of 14).
Price implies For today's price to make sense, revenue must grow about 6% a year for seven years (Req g). Recent delivered growth is +16%, so the hurdle is -9 pp: the price already allows for a slowdown.
Capital Return on invested capital runs 3.6 points above its cost of capital (10.0% WACC).
Next results Next results expected around 10 Mar 2027 (exchange calendar; dates can move).
| TTM | FY2025 | FY2024 | FY2023 | FY2022 | |
|---|---|---|---|---|---|
| Revenue | $302M | $270M | $224M | $183M | $139M |
| Revenue growth | — | +21% | +23% | +32% | — |
| Gross profit | $172M | $154M | $132M | $111M | $83.7M |
| EBITDA | $55.8M | $50.4M | $40.3M | $37.4M | $24.2M |
| Net income | $14.5M | $14.9M | $11.3M | $10.2M | $6.22M |
| Free cash flow | $29.2M | $11.9M | $1.32M | $19.1M | $4.85M |
| Capital expenditure | $31.5M | $40.0M | $37.8M | $26.1M | $22.9M |
| Total debt | $11.6M | $15.9M | $6.87M | $10.3M | $694,000 |
The default views of Competitor Analysis ▸ Charts, drawn from the same data. Open them in the cockpit to change the axes, pin companies and read every value.
Peer set: Industry: the same industry and sector in any market, nearest in size. This is the same default set the interactive Competitor Analysis opens with.
| Measure | VMD | Peer median | Rank in peer set |
|---|---|---|---|
| 1-month return | -3.0% | -0.7% | 10th lowest of 20 |
| 6-month return | +2.1% | -7.2% | 8th highest of 20 |
| Distance from 52-week high | -27.6% | -22.6% | 6th lowest of 20 |
| Revenue growth (TTM) | +25.2% | +10.9% | 2nd highest of 21 |
| Operating margin | 8.5% | 9.5% | 9th lowest of 21 |
| Forward P/E | 18.1× | 22.5× | 5th cheapest of 14 |
| Growth the price implies (Req g, 7 yrs) | 6.2% | 4.1% | 8th least demanding of 15 |
| Growth delivered (Del g) | +15.5% | +13.9% | 7th highest of 15 |
| Hurdle (Req g minus delivered) | -9.4 pp | -5.0 pp | 7th least demanding of 15 |
| ROIC minus cost of capital | +3.6 pp | +1.0 pp | 6th highest of 21 |
| EV / EBITDA | 6.3× | 12.4× | 3rd cheapest of 19 |
| Net debt / EBITDA | 0.0× | 0.6× | 6th least indebted of 19 |
| Company | Market | Market cap | 6M return | Revenue growth | Op. margin | Forward P/E | Req g | Delivered g |
|---|---|---|---|---|---|---|---|---|
| Viemed Healthcare VMD | United States | $348M | +2% | +25% | 8% | 18.1× | 6.2% | +15.5% |
| Q & M Dental Group (Singapore) QC7.SI | Singapore | $353M | -18% | +16% | 9% | 34.5× | 8.2% | +7.5% |
| Liaoning He Eye Hospital 301103.SZ | China | $365M | -21% | +3% | 4% | n/a | -2.1% | +5.4% |
| Indraprastha Medical INDRAMEDCO.NS | India | $321M | -21% | +11% | 15% | 14.7× | 16.7% | +19.3% |
| Community Health Systems CYH | United States | $312M | -21% | -8% | 7% | n/a | n/a | n/a |
| Voxel VOX.WA | Poland | $405M | +50% | +14% | 24% | 13.7× | 1.1% | +12.2% |
| China Resources Medical 1515.HK | Hong Kong | $415M | -12% | 0% | 6% | 5.7× | -7.3% | +26.3% |
| Bright Eye Hospital 301239.SZ | China | $419M | -23% | +11% | 9% | 46.2× | -3.7% | +15.5% |
| MEDICLIN Aktiengesellschaft MED.DE | Germany | $285M | +48% | +3% | 8% | 6.8× | -9.1% | +3.5% |
| Bayzed Health 2609.HK | Hong Kong | $453M | -49% | -2% | 5% | n/a | 17.4% | +9.2% |
| Artemis Medicare Services ARTEMISMED.NS | India | $514M | +16% | +15% | 14% | 37.6× | 45.8% | +21.5% |
| Garofalo Health Care GHC.MI | Italy | $540M | +1% | +4% | 10% | 20.9× | 1.8% | +18.3% |
| Kovai Medical Center & Hospital KOVAI.NS | India | $689M | +4% | +15% | 21% | n/a | 16.3% | +18.1% |
| Paras Healthcare PARASHLTH.NS | India | $844M | n/a | +24% | 11% | n/a | n/a | n/a |
| Clinica Baviera CBAV.MC | Spain | $940M | -7% | +11% | 20% | 18.2× | 0.7% | +19.7% |
| HealthCare Global Enterprises HCG.NS | India | $950M | -2% | +14% | 8% | 67.3× | n/a | n/a |
| Thomson Medical A50.SI | Singapore | $953M | -21% | +6% | 10% | n/a | 20.9% | +11.8% |
| Jupiter Life Line Hospitals JLHL.NS | India | $1,000M | +14% | +17% | 16% | 48.5× | n/a | n/a |
| Yatharth Hospital and Trauma Care Services YATHARTH.NS | India | $1.05B | +25% | +50% | 16% | 41.0× | n/a | n/a |
| Rhon-klinikum RHK.DE | Germany | $1.08B | +14% | +5% | 3% | 22.5× | n/a | n/a |
| Ramsay Generale de Sante GDS.PA | France | $1.09B | -15% | +3% | 4% | n/a | 6.3% | +6.0% |